Drawing for BEXSON

USPTO serial 97583883

BEXSON

Reviewed by CopyMark Law Group

Status 807Office Action
Filing date
Status date
Registration date
—
Examiner
ALTREE, NICHOLAS
Law office
TMEG LAW OFFICE 107

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with BEXSON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnessesACTIVE—
010wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnessesACTIVE—
035providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices thereforACTIVENov 18, 2019
042medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drugy delivery devices thereforACTIVENov 18, 2019
044providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices thereforACTIVENov 18, 2019
045providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices thereforACTIVENov 18, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Nov 6, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 13, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 29, 2026IUAFUSE AMENDMENT FILED—
Sep 29, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 2, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 2, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 22, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 27, 2026EXT5SOU EXTENSION 5 FILED—
Mar 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2025EX4GSOU EXTENSION 4 GRANTED—
Oct 10, 2025EXT4SOU EXTENSION 4 FILED—
Oct 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 8, 2025EX3GSOU EXTENSION 3 GRANTED—
Apr 8, 2025EXT3SOU EXTENSION 3 FILED—
Apr 8, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 4, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 4, 2024EXT2SOU EXTENSION 2 FILED—
Oct 4, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 16, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 9, 2024EXT1SOU EXTENSION 1 FILED—
Apr 9, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 12, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jul 12, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 12, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 12, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 11, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 11, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 11, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 10, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023DOCKASSIGNED TO EXAMINER—
Sep 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance